British Columbia is home to a province-wide community of kidney care professionals and research teams involved in a broad range of local, provincial and international research projects. Their work is enabled through a robust provincial research infrastructure that includes various resources, supports and tools offered by academic institutions, health authorities, research institutes, research funders, and organizations focused specifically on kidney care and research.
View our partner organizationBy helping BC researchers access resources and engage with the broader kidney research community in the province, the BC Kidney Research Collaboratory plays an important supportive role for enabling high quality kidney research.
BC’s Research Assets
Provincial data source
An important resource for kidney researchers is BC’s Patient-Reported Outcomes Measurement Information System (PROMIS). The only database of its kind in Canada, PROMIS is an integrated provincial registry and clinical information system that houses health data for every kidney disease and transplant patient living in British Columbia. The Collaboratory team can help researchers navigate access to the data held in PROMIS and other databases.
Researchers who wish to access PROMIS data must complete an Information Sharing Agreement.
Kidney research specialties
British Columbia is home to clinicians and researchers with expertise in the following areas:
- Chronic kidney disease (CKD) management
- Dialysis management
- Glomerulonephritis (GN)
- Genetic and/or rare kidney disease, biomarkers
- Outcomes on disease progression
- Diet, Nutrition and Metabolism
- Infections and complications
- Economic impact of CKD
- Environment and sustainability
- Medication adoption
- Risk prediction
- Artificial intelligence
Clinical trials expertise
BC has built an international reputation for clinical trial excellence related to kidney disease. BC kidney researchers are involved in or leading many clinical trials to improve quality of care and outcomes for patients.
Patient partners in research
Kidney research benefits from the involvement of BC patients living with kidney disease. In addition to participating in clinical trials, patients can be involved as research partners, helping inform research priorities and processes. The following resources can help you learn more about involving patient partners in your research projects.
- Patient Engagement (Can-SOLVE CKD Network)
- Patient and Family Engagement (BC Renal)
- Lived Experience Expertise (Kidney Foundation)
- Patient-Oriented Research (BC SUPPORT Unit)
Improving patient care
BC’s kidney care system features a close connection between research and clinical care. Kidney researchers strive to ensure their research is put into practice, sharing their work at province-wide clinical rounds and collaborating with clinicians to make sure new knowledge is translated into improved patient care.
In addition to more traditional research, health authority renal/kidney program clinicians work to advance kidney care through ongoing quality improvement. In fiscal 2025/26, there were more than 40 quality improvement projects underway across all regions of the province. Projects range from improving physician teaching materials for pediatric kidney care to developing virtual reality training materials for patients who are doing home hemodialysis.
Research productivity
Drawing from PROMIS data and BC’s robust research infrastructure, BC-based kidney researchers have an international reputation for excellence. Their work is regularly published in high-quality peer-reviewed journals. The Collaboratory has supported more than 400 of these papers over the past 10 years, as illustrated in the following graph.
Publications
Below is a partial list of publications involving BC researchers across all nephrology subject categories.
2026 Publications
- Han J, Canney M, Zhao Y, Atiquzzaman M, Levin A, Barbour S J. (2026). Cancer Incidence in People With Glomerular Disease: A Population-Level Study. AJKD
- Wong MY M, Birks P, Enilama O, Yu SW J, Singh A, Levin A. (2026). A Multipronged Intervention to Improve Outpatient Care Following Hospitalization With Acute Kidney Injury: An Implementation Study Protocol. CJKHD
- Yi TW, O’Hara D. V., Levin A. (2026). Global kidney health: Are we failing the silent pandemic? J. Intern Med.
- Pergola P, Johnson R, Levin A, Stenvinkel P. (2026). Chronic Inflammation as an Overlooked Link Between Cardiovascular and Kidney Disease: A Focus on Interleukin-6 and C-Reactive Protein. CJASN
- Cau A, Stigant C, Levin A, Singh S. (2026). Frequency of Routine Bloodwork Among Patients With Chronic Kidney Disease: A Narrative Review to Inform Appropriateness of Care. CJKHD
- Tungsamga S, Levin A, et al. (2026). Bridging global kidney care gap through data: introducing the International Society of Nephrology–Global Kidney Health Atlas (ISN-GKHA) Interactive Map. KI. 109, 242-247
- Singh A, Elliott M, Levin A. (2026). Virtual Care Utilization and Peritonitis Risk in Rural and Indigenous Peritoneal Dialysis Patients. Kidney Int Rep
2025 Publications
- Sandal S, Wazze S E, Stigant C E, Martens N, THomas S, et al. (2025).From Risk and Vulnerability to Preparedness and Resiliency: An Opinion Piece on Championing Disaster and Emergency Risk Reduction and Management in Kidney Care. CJKHD
- Wehbe F, Elliott M, Levin A. (2025). CKDs at the Crossroads: From Failures to Future Therapies. KI Reports
- Lafayette R, Barbour S J, et al. (2025). A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy. NEJM
- Singh A, Liaqat A, Walkey K, Stoppler A. (2025). WCN25-4542 Virtual Care is a barrier to sustaining trusting relationships and optimal clinical outcomes for Peritoneal Dialysis patients from Rural and Indigenous Communities. KI Reports. 2025 Feb; 10(2):S676-S677
- Fung W WS, Stigant C. (2025). A guide for program development of environmentally sustainable kidney care. Nephrology and Hypertension.
- Saleem S, Stigant C, et al. (2025). Environmental Impacts of Kidney Replacement Therapies: A Comparative Lifecycle Assessment. AJKD
- Levin A, et al. (2025).Changing paradigms of studies in kidney diseases. KI
- Tait T, Turner C, Levin A, et al. (2025). Global landscape of kidney health across Indigenous populations. Nature Reviews Nephrology
- Rifkin B, Levin A. (2025). Screen, Stratify, and Treat: Data to Drive Worldwide CKD Health Policy. KI Reports
- Thomas S. (2025). Building Resilience in Hemodialysis Care: A Program Report on the British Columbia Hemodialysis Emergency Support Team. CJKHD
- Taber D J, Gill J S, et al. (2025). Therapeutic needs in solid organ transplant recipients: The American Society of Transplantation patient survey. Am J Transplant
- Floege J, Lafayette R, Barratt J, Schwartz B, Manser PT, Patel UD, Shah M, Kivman L, Faulhaber N, Kräft T, Thakur A, Härtle S, Barbour SJ. (2025). Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathy. Kidney Int. 2025 Jun 26:S0085-2538(25)00488-0
- Ghaddar M, Caravaca-Fontán F, Praga M, Fernández-Juárez G, Lomax-Browne HJ, Cook HT, Daina E, Noris M, Remuzzi G, Induruwage D, Zhu B, Pickering MC, Barbour SJ (2025). Clinical and Histologic Predictors of Kidney Outcomes in C3 Glomerulopathy and Idiopathic Membranoproliferative GN. Clin J Am Soc Nephrol. 2025 Jun 13;20(8):1119-1131
- Andeen NK, Kung VL, Avasare RS, Barbour S, Griffith M, Bissonnette MLZ, Roufosse C. (2025). Questions and Caveats in Antigen-Defined Membranous Nephropathy. J Am Soc Nephrol. 2025 May 27;36(8):1639-1651
- Barbour SJ, Coppo R, Barratt J, Er L, Lafayette R, Heerspink HJL, Rizk DV, Liew A, Jha V, Zhang H, Suzuki Y, Trimarchi H, Cattran DC; International IgA Nephropathy Network Research Group. (2025). Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts.. Kidney Int Rep. 2025 Jan 20;10(4):1283-1287
- Barbour SJ, Ronco P, Praga M, Fervenza FC, Induruwage D, Zhu B, Debiec H, Fernández-Juárez G, Caravaca-Fontán F, Cattran DC; GEMRITUX, MENTOR and STARMEN investigators. (2025). Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials. Clin J Am Soc Nephrol. 2025 Apr 14;20(6):854-865
- Canney M, Atiquzzaman M, Zheng Y, Induruwage D, Zhao Y, Er L, Fordyce CB, Barbour SJ. (2025). Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseases. Kidney Int. 2025 Jan;107(1):143-154
- Barratt J, Barbour SJ, Brenner RM, Cooper K, Wei X, Eren N, Floege J, Jha V, Kim SG, Maes B, Phoon RKS, Singh H, Tesař V, Lafayette R; ORIGIN Phase 2b Investigators. (2025). Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy. J Am Soc Nephrol. 2025 Apr 1;36(4):679-687
- Hughes A, Levin A et al. (2025). Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic review. BMJ
- Yousafzai S, Stigant C, et al. (2025). Life Cycle Assessment: A Primer for Kidney Professionals. CJKHD
- Chiu H HL, Duncan J, Hargrove G, et al. (2025). Enablers and Barriers to Integrating Advance Care Planning in Chronic Kidney Disease Care in a Canadian Provincial Network. CJKHD
- Sridhar V, et al. (2025). Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney Disease. ASN 2025; 36(7): 1414-1416
- Sandal S, Stigant C, et al. (2025). A Roadmap for Disaster Risk Reduction and Management in Kidney CareA Scoping Review and Content Analysis. JASN 2025; 36(7):1363-1379
- Hughes A, Gonzelaz A, Levin A, et al. (2025). Core Outcome Measure for Life Participation in Patients with Chronic Kidney Disease: Standardized Outcomes in Nephrology Workshops Report. CJASN
- Lala A, Levin A, Khunti K (2025). The interplay between heart failure and chronic kidney disease. Diabetes Obes Metab
- Yi TW, Wong M MY, Picard K, Renouf K, Levin A. (2025).Managing hyperkalemia in the outpatient setting. BCMJ 2025; 67(3)
- Madero M, Levin A, et al. (2025). Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline. Annals of Internal Medicine
- Siriwardana A, Levin, et al. (2025). Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial . Diabetes Obes Metab. 2025; 27(4):1972-1979
- Pietrobon A and Elliott M. (2025). Chronic Benign Tubular Albuminuria from Compound Heterozygous Variants in CUBN: A Case Study. JASN
- Kistler B M, Biruete A, Wong M MY, et al. (2025). Homemade formulas for nutrition support in chronic kidney disease: A narrative review of the opportunity for education, research, and innovation. NCP
- Ghaddar M, et al. (2025). Risk of Postoperative Hypermagnesemia in Cardiopulmonary Bypass–Assisted Cardiovascular Surgery. Kidney360 6(2):219-226
- Hughes A, Ju A, Cazzolli R, Howell M, Levin A, et al. (2025). Patient-reported outcome measures for life participation in patients with chronic kidney disease: a systematic review. KIR
- Wazze S E, Nijjar D, Ethier I, Paparella A, Hales L, Finkle N, Jha V, Stigant C. (2025). A Roadmap for Disaster Risk Reduction and Management in Kidney Care: A Scoping Review and Content Analysis. JASN
- Romagnani P, Agarwal R, Chan J CN, Levin A (2025).Chronic kidney disease. Nature Reviews
- Pietrobon A, Elliott M (2025). Chronic Benign Tubular Albuminuria From Compound Heterozygous Variants in CUBN: A Case Report. CJKHD
- Siddiqi T J, Cherney D, Siddiqui H F, Jafar T H, Khan J, Levin A, et al. (2025). Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions. CJASN 26(2):242-255
- Brum I S C, Cardozo L F M F, Alvarenga L, Kemp J A, Baptista B G, Britto I K, Borges N A, Renouf D, Wong M MY, et al. (2025). Fad diets for non-dialysis chronic kidney disease patients: Can “the miracle diet” be a threat? Nutrition
- Elliot M D, Gharaavi A G, et al. (2025). Increased risk of kidney failure in patients with genetic kidney disorders. Journal of Clinical Investigation 134(17):e178573
- Verdin N, Black A, Stigant C. (2025). Environmental Sustainability Is Needed in Kidney Care: Patient, Donor, and Provider Perspectives Canadian Journal of Kidney Health and Disease 2025;12. doi:10.1177/20543581241308642
2024 Publications
- Kadatz M, Klarenbach S, So H, Fervenza F C, Cattran D C, Barbour S J and MENTOR Study Investigators. (2024). Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial. NDT 2024 Dec; 39: 2058-2066
- Barbour SJ, et al. (2024). Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy. KI; 106(5):913-927
- Kim D, Barbour SJ, et al. (2024). The Efficacy and Safety of Reduced-Dose Oral Methylprednisolone in High-Risk Immunoglobulin A Nephropathy. KI; 9(7):2168-2179
- Canney M, Atiquzzaman M, Induruwage D, Er L, Barbour SJ, et al.(2024). Evaluating the risk of cardiovascular events associated with different immunosuppression treatments for glomerular diseases. KI
- Barratt J, Barbour SJ, et al. (2024). Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy. JASN; 36(4):679-687
- Barbour SJ. (2025). The epidemiology of IgA nephropathy: East versus West. Nephrology; 29(S2):65-67
- Ethier I, Sandal S, Tarakji A R, Finkle S N, Kahlon B, Pederson K, Samanta R, Stigant C. (2024). Climate Change and Environmentally Sustainable Kidney Care in Canada: A Knowledge, Attitudes, and Practices Survey of Kidney Care Provider. CJKHD 2024 October
- Wang C, Naylor K L, McArthur E, Sontrop J M, Roshanov P, Lam N N, McDonald S D, Lentine K L, King J, Youngson E, Beyene J, Hendren E, Garg A X. (2024). Pregnancy Outcomes in Living Kidney Donors: Protocol of a Population-Based Cohort Study in Three Canadian Provinces. CJKHD 2024 October
- Elliott M D, Vena N, Marasa M, et al. (2024). Increased risk of kidney failure in patients with genetic kidneydisorders. J Clin Invest 2024;134)17):e178573
- Okpechi I G, Tummalapalli S L, Levin A, et al. (2024). A global assessment of kidney care workforce. Nephrol Dial Transplant 2024; 39:ii43-ii48
- Ting R, Borkum M, Ni L T, Levin A. (2024). Patient screening and assessment for home dialysis therapies: A scoping review. Peritoneal Dialysis International 2024 August
- Poinen K, Mitra S, Quinn R R. (2024). The integrated care model: facilitating initiation of or transition to home dialysis. CKJ 2024
- Cardoza K, Kang A, Yi T W, Levin A, et al. (2024). Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial in Diabetes. Diabetes, Obesity and Metabolism
- Cheng X B J and Bargman J. (2024). Complications of Peritoneal Dialysis – Part 1. CJASN 2024 June; 19(6):784-790
- Cheng X B J and Bargman J. (2024). Complications of Peritoneal Dialysis – Part 2. CJASN 2024 June; 19(6):p.791-799
- Chertow G M,Chang AM, Felker G M, Levin, A, et al. (2024). IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature Medicine 2024 May; 30, 2328-2336
- Aiyegbusi I, Gradin S, Rajmohan Y, Zhu B, Romann A, Chiu H, Gill J, Johnston O, Bevilacqua B. (2024). Opportunities for Improving the Transplant Assessment and Education Process in British Columbia: Patient and Health Care Provider Perspective. CJKHD 2024 May
- Affdal A, Issa M, Ballesteros F, Malo MF, Thind G, Lan H H. (2024). Kidney transplant candidates’ perspectives on the implementation of a CanadianWillingness to Cross program: A strategy to increase access to kidney transplantation for highly sensitized patients. Clinical Transplantation
- Zoccali C, Mallamaci F, Lightstone L, Jha V, Pollock C, Tuttle K, Kotano P, Levin A, et al. (2024). A new era in the science and care of kidney diseases. Nature Reviews Nephrology
- Renouf D, Wong M MY. (2024). From Prophecy to Plate: How to Actualize a Planetary Menu for Kidney Disease Nutrition. CJKHD
- Vendeville N, Lepage MA, Festa M C, et al. (2024). Clinical Outcomes of Renin-Angiotensin Aldosterone Blockade in Patients with Advanced Chronic Kidney Disease: A Systematic Review and Meta-Analysis. CJC April 2024
- Naik H, Tran K C, Staples J A, Perlis R H, Levin A. (2024).Psychiatric Symptoms, Treatment Uptake, and Barriers to Mental Health Care Among US Adults With Post–COVID-19 Condition. JAMA. 2024 April; 7(4): e248481
- Lafayette R, Barbour S, Israni R, Wei X, et al. (2024). A Phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy. Kidney Int March 24 2024
- Enilama O, MacDonald C, Levin A, et al. (2024). Perceptions and Information-Seeking Behavior Regarding COVID-19 Vaccination Among Patients With Chronic Kidney Disease in 2023: A Cross-Sectional Survey. CJKHD 2024
- Karam S, Amouzegar A, Alshamsi I R, Levin A, et al. 2024). Capacity for the management of kidney failure inthe International Society of Nephrology Middle East region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr; 13(1): 57-70
- Calice-Silva V, Neyra J A, Fuentes A F, Levin A, et al. (2024). Capacity for the management of kidney failure inthe International Society of Nephrology Latin America region: report from the 2023 ISN GlobalKidney Health Atlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr; 13(1): 43-56
- Tran J, Alrajhi I, Chang D, Sherwood K R, Keown P, Gill Jag, Kadatz M, Gill John, Lan J H. Clinical relevance of HLA-DQ eplet mismatch and maintenance immunosuppression with risk of allosensitization after kidney transplant failure. Frontiers in Genetics 2024
- Zoccali C, Mallamaci F, Lightstone L, Levin A, et al. (2024). A new era in the science and care of kidney diseases. Nature Reviews Nephrology 2024
- Tanner E J, Davidson B, Levin A, et al. (2024). Capacity for the management of kidney failure inthe International Society of Nephrology Africa region: report from the 2023 ISN Global KidneyAtlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr;13(1)12-28
- Chiu H, Lee B, Bennett L, Spensley J, Dear W, Koo W, Saunders S, Freeborn G. (2024). GROWING A PROVINCIAL PATIENT AND FAMILY ENGAGEMENT NETWORK TO OPTIMIZE KIDNEY CARE. Health Management Forum 2024
- Lowe-Jones R, Ethier I, Fisher LA, Wong M MY, Thompson S, Nakhoul G, Sandal S, Chanchlani R, Davison S N, Ghimire A, Jindal K, Osman M A, Riaz P, Saad S, Sozio S M, Tungsanga S, Cambier A, Arruebo S, Bello A K, Caskey F J, Damster S, Donner J, Jha V, Johnson D W, Levin A, et al. (2024). Capacity for the management of kidney failure in the International Society of Nephrology North America and the Caribbean region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA).Kidney Int Suppl. 2024 Apr;13(1):83-96
- Prikhodina L, Komissarov K, Bulanov N, Arruebo S, Bello A K, Caskey F J, Damster S, Donner J, Jha V, Johnson D W, Levin A, et al. (2024). Capacity for the management of kidney failure inthe International Society of Nephrology NewlyIndependent States and Russia region: report fromthe 2023 ISN Global Kidney Health Atlas (ISN-GKHA) Kidney Int Suppl. 2024 Apr;13(1)71-82
- Fung W WS, Park H C, Hirakawa Y, Arruebo S, Bello A K, Caskey F J, Damster S, Donner J, Jha V, Johnson D W, Levin A, et al. (2024). Capacity for the management of kidney failure inthe International Society of Nephrology North and East Asia region: report from the 2023 ISN GlobalKidney Health Atlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr; 13(1): 97-109
- Francis A, Wainstein M, Irish G, Hafidz M I A, Chen T, Cho Y, Htya H, Kanjanabuch T, Lalji R, Neuen B L, See E, Shah A, Smyth B, Tungsanga S, Viecelli A, Yeung E K, Arruebo S, Bello A K, Caskey F J, Damster S, Donner J, Jha V, Johnson D W, Levin A, et al. (2024). Capacity for the management of kidney failure in the International Society of Nephrology Oceania and South East Asia (OSEA) region: report from the2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr; 13(1):110-122
- Bello A K, Okpechi I G, Levin A, Johnson D W. (2024). Variations in kidney care management and access: regional assessments of the 2023International Society of Nephrology Global KidneyHealth Atlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr; 13 (1):1-5
- Okpechi I G, Bello A K, Levin A, Johnson D W. (2024). Update on variability in organization and structures of kidney care across world regions. Kidney Int Suppl. 2024 Apr; 13(1):6-11
- Wijewickrama E, Alam M R, Bajpai D, Divyaveer S, Iyengar A, Kumar V, Quayyum A, Yadav S P, Yadla M, Arruebo S, Bello A K, Casky F J, Damster S, Donner J, Jha V, Johnson D W, Levin A, et al. (2024). Capacity for the management of kidney failure in the International Society of Nephrology South Asia region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr; 13(1):123-135
- Pippias M, Alfrano G, Kelly D M, Soler M J, De Chiara L, Olanrewaju T O, Arruebo S, Bello A K, Caskey F J, Damster S, Donner J, Jha V, Johnson D W, Levin A, et al. (2024).Capacity for the management of kidney failure in the International Society of Nephrology Western Europe region: report from the 2023 ISN Global Kidney Health Atlas (ISN-GKHA). Kidney Int Suppl. 2024 Apr; 13(1):136-151
- Loban K, Fadel E, Nugus P, Przybylak-Brouillard A, Badenoch H, Robert JT, Begeja A, Gill J, Fortin MC, Rodriguez C, Sandal S. (2024). Living kidney donors’ health care needs, experiences, and perspectives across their entire donation trajectory: a semistructured, in-depth interview study. Kidney International 2024; 105(2): P251-258
- Thomas S, Kennett A, Fullerton C, Boyd H. (2024). Nephrology Nurses: Essential Professionals in Sustainable Kidney Care. CJKHD 2024
- Renouf D, Wong M MY. (2024). From Prophecy to Plate: How to Actualize a Planetary Menu for Kidney Disease Nutrition. CJKHD
- Birks P, Al-Zeer B, Holmes D, Elzayat R, Canney M, Djurdjev O, Shao T S, Zheng Y, Silver S A, Levin A. (2024). Assessing Discharge Communication and Follow-up of Acute Kidney Injury in British Columbia: A Retrospective Chart Review. CJKHD 2024
- Atiquzzaman M, Er L, Djurdjev O, Bevilacqua M, Elliott M, Birks P C, Wong M MY, Yi TW, Singh A, Tangri N, Levin A. (2024). Implications of Implementing the 2021 CKD-EPI Equation Without Race on Managing Patients With Kidney Disease in British Columbia, Canada. KI 2024
- Atiquzzaman M, Zhu B, Romann A, Er L, Djurdjev O, Bevilacqua M, Wong M MY, Birks P, Yi TW, Singh A, Tangri N, Levin A. (2024). Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making. CKJ 2024 February; 17(2)
- Bello A K, Okpechi I G, Levin A, et al. (2024). An update on the global disparities in kidney disease burdgen and care across world countries and regions. Lancet Glob Health 2024 March;12(3):e382-395
- Ghimire A, Shah S, Okpechi I G, Ye F, Tungsanga S, Vachharajani T, Levin A, et al. (2024). Global variability of vascular and peritoneal access for chronic dialysis. Nephrology 2024 March; 29(3):135-142
- Borkum M, Levin A, Ficocelli J, Wone L, Kiaii M. (2024). A Current State of the Art and Science of Exercise in Dialysis: A Narrative Review. CJKHD 2024
- Wong M M Y, Zheng Y, Zhu B, Er L, Atiquzzaman M, Romann A, Renouf D, Sheriff Z, Levin A (2024). Oral Nutritional Supplement Prescription and Patient-Reported Symptom Burden Among Patients With Late-Stage Non-Dialysis Chronic Kidney Disease. CJKHD 2024
- Lan, J H (2024). Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape. JASN February 2024
- Sharma A, Razaghizad A, Joury A, Levin A, Bajaj H S, Mancini GB J, Wong N C, Slee A, Ang F G, Rapattoni W, Neuen B L, Arnott C, Perkovic V, Mahaffey K W. (2024). Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. JAHA
- Enilama O, Yau K, Er L, Atiquzzaman M, Oliver M J, Romney M G, Leis J A, Abe K T, Qi F, Colwill K, Gingras AC, Hladunewich M A, Levin A. (2024). Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study. CJKHD 2024
- Gage B, Shalansky K, Lau W, Harris C, Kiaii M. (2024). Comparison of Tetrasodium EDTA 4% with Sodium Citrate 4% as Line-Locking Solutions at 2 Tertiary Hemodialysis Centres. CJHP 2024
- Levin A. (2024). Overcoming barriers to deliver high quality kidney care. Nature Reviews Nephrology
- Cheng X B J, Bargman J. Complications of Peritoneal Dialysis Part II Nonmechanical Complications. CJASN
- Cheng X B J and Chan C T. (2024). Systems Innovations to Increase Home Dialysis Utilization. CJASN 2024 January; 19(1):108-114
- Atiquzzaman M, Zhu B, Romann A, Er L, Djurdjev O, Bevilacqua M, Wong M, Birks P, Yi T W, Singh A, Tangri N, Levin A. (2024). Kidney Failure Risk Equation in vascular access planning: a population-based study supporting value in decision making. Clinical Kidney Journal January 2024
Additional publications can be found on the BC Renal website.